We are pleased to announce that CMT Solutions has been named a 2020 Northern Virginia Technology Council (NVTC) Tech 100 honoree.Continue reading
The ACOG and SMFM released new guidelines in October 2020, advocating that all pregnancies be screened with NIPT, regardless of maternal age or risk. Tune into an educational video with Dr. Lee Shulman MD and Dr. Caroline Ross MD.Continue reading
For Women’s History Month, we are celebrating one of CMT Solutions first women to join the company! Lynda Bernard, joined us 2 years ago today as the Director of Operations for CMT Solutions. She’s a leader in her field with nearly 20 years of experience in Revenue Cycle & Reimbursement Management, focused exclusively in healthcare. Lynda’s concentrations are in GYN care, Clinical, Diagnostic/ Genetic & Molecular Labs. Previous to her position at CMT, she served as Operations Manager at Amerisource Bergen (Lash Group) for Revenue Cycle/ Diagnostic Hub Services.
Outside of work, Lynda devotes a significant amount of her time to philanthropic work by serving as Co-Founder to Project St. Anne.org, an international non- profit organization whose mission is to enrich the lives of communities in Camp Perrin, Haiti. Lynda and her team have been providing nutritional, financial, and educational support to thousands of families since 2008. She has lead several missions to Haiti, and her organization has provided relief to thousands in times of natural disasters. Today she and her team are focused on their educational program, and the start of construction of their elementary school, to continue an avenue of advancement for their children. Lynda strongly believes that equipping the less fortunate will positively change the dynamics of their lives, and that of their communities. She is passionate about giving back, and treating all with dignity. She believes that access to education is key. Aside from her family this is one of Lynda’s greatest joys, and her utmost wish is to one day remove the need for charity in the lives of families in the first place. To learn more about Lynda’s charitable work, please visit: www.Projectstanne.org
Happy 2 year anniversary Lynda!
Coronavirus Disease or COVID-19 is the name for the respiratory syndrome caused by infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
CMT Solutions continues to closely monitor the situation. Our priority is the health and safety of our employees, patients, physicians, laboratories, and the communities we serve. We want to help reduce the risk of spread and exposure while at the same time providing our high quality of services under these challenging conditions.
We are making sure that we are staffed and operational to help our partners and patients with all their laboratory diagnostic testing needs.
Our company has multiple physical CMT locations that our employees can work out of, as well as remote employees, giving flexibility and optimal sourcing to continue to perform our necessary workflow. CMT currently has 5 operations employees that are dedicated remote staff.
The team here is currently preparing to have all of our operations employees equipped with the ability to work remotely, if it is necessary for them to do that. Additionally, we are communicating the requirements of working remotely, given the complexity and security of the nature of our work.
For those who have been directly affected by the COVID-19 you are in our thoughts. Now is a time to come together and help and support one another as we find our way through this challenging time.
Please refer to the CDC website for the most current information about COVID-19, or to your local / state health authorities for information pertaining to your area.
On behalf of CMT Solutions, we thank all of our employees, community, laboratories, providers and patients as you continue to partner with us and trust our solutions.
We will continue to keep you updated if our conditions change and we are committed to adapting with the changes.
January Employee Spotlight – John Pavlovich
At our January CMT Solutions company meeting, our employee spotlight featured our CFO/COO John Pavlovich! John shared with the company his love for hiking outdoors, spending time with his family, and his very first job was weeding a nursery garden that was out of business! John, you sure have come a long way, CMT Solutions is so proud to have you head up our operations. With your leadership, we are able to serve 100,000 patients and we keep growing every day -helping patients, physicians, and laboratories.
CMT Solutions is proud to see our Orlando Operations HubCenter grow! We recently expanded with an additional 3,000 square feet.
“This allows us to increase in the coming months up to 30 Patient Access Specialists in the Orlando office, further helping physicians and their patients treat their condition or disease through genetic testing” says John Pavlovich, CMT’s CFO and COO.
CMT first moved into their existing office back in May 2019, and this space provides room for expansion as the company enrolls new physician offices, partners with additional laboratories, and launches new services. The expansion will provide both work and meeting space as the team is currently outgrowing their initial surroundings.
This news continues CMT’s long term strategy of building an Orlando based operations team, in a location known for having deep experience in healthcare administration. “We continue to attract experienced team members and are always looking to add quality people who are a great fit for our company.”
CMT Solutions achieved a milestone event to close out 2019, we received our 100,000 patient service case. Achieving 100,000 patients is a major milestone for the company. In less than two years of being in business, we have helped 100,000 patients get access to the testing that they need, helping them better manage their condition or disease. In 2019, we have launched new services, including genetic counseling and benefits investigations.
Congratulations to the entire team and we look forward to the next milestone in 2020.
CMT held is annual Thanksgiving Feast at the Orlando office.
The employees at CMT Solutions took time to support the breast cancer community and each other by raising awareness about the disease, it’s reach and impact.
There are many of us who have been affected by breast cancer, whether it is knowing someone who has fought the disease, being diagnosed ourselves, or being active in the prevention and screening awareness. Early detection can protect ourselves from breast cancer. Stage 0 and Stage 1 breast cancer have over a 99% 5-year survival rate. Everyone should assess their own personal risk of breast cancer. If you have had a family member that had a certain type of cancer, you may have an elevated risk for yourself. Have a conversation with your healthcare provider, and if your risk is elevated especially, consider diagnostic testing to assess your risk.
Here at CMT, we work with physicians and laboratories who order and perform diagnostic testing for breast cancer and oncology. We recognize the importance of this test to patients, their family, and the community. We will continue to perform our jobs at the highest level of service and dedication to our partners and clients.
This was originally published on Health Affairs on October 23rd, 2019, written by Kathryn A. Phillips, Patricia A. Deverka.
Our newly released study examines the increasingly important but poorly understood role of Lab Benefit Managers (LBMs).Pharmaceutical Benefit Managers (PBMs) have generated widespread attention (often negative), but little attention has been paid to the rapid growth of LBMs. LBMs now manage genetic test benefits for hundreds of millions of enrollees and three of the four largest health plans in the U.S. use LBMs to manage genetic testing. These third party benefit managers are changing clinical and lab practice in significant ways. For example, some LBMs require prior authorization for all genetic tests, which has important implications for patients and providers, and some develop coverage policies on behalf of payers, thus changing the nature of coverage policy development in the U.S.
This is the first study to our knowledge to examine the growth and role of LBMs. We describe the LBM landscape including the major players as well as the types of services LBMs offer to providers and labs on behalf of payers. Next, we attempt to apply lessons learned from recent observations regarding PBMs to LBMs in the hopes of avoiding some of the potential negative consequences of introducing misaligned incentives among patients, clinicians, labs and insurers. While the LBM business model is distinct from PBMs, it is instructive to look more closely at the current reach of LBMs to see how the use of intermediaries might affect genetic test access, costs, and utilization over time. Finally, we outline trends to watch to develop transparent, objective evidence about the impact of LBMs on patient outcomes, and to assess trade-offs between benefits and harms from tighter utilization management practices.
This article was from the Health Affairs Blog: https://www.healthaffairs.org/do/10.1377/hblog20191021.563154/full/